首页 > 最新文献

International Journal of Alzheimer's Disease最新文献

英文 中文
Cholesterol and copper affect learning and memory in the rabbit. 胆固醇和铜会影响兔子的学习和记忆。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-08-29 DOI: 10.1155/2013/518780
Bernard G Schreurs

A rabbit model of Alzheimer's disease based on feeding a cholesterol diet for eight weeks shows sixteen hallmarks of the disease including beta amyloid accumulation and learning and memory changes. Although we have shown that feeding 2% cholesterol and adding copper to the drinking water can retard learning, other studies have shown that feeding dietary cholesterol before learning can improve acquisition and feeding cholesterol after learning can degrade long-term memory. We explore the development of this model, the issues surrounding the role of copper, and the particular contributions of the late D. Larry Sparks.

一种阿尔茨海默病的兔子模型,在喂食胆固醇食物8周的基础上,显示出这种疾病的16个特征,包括-淀粉样蛋白积累、学习和记忆变化。虽然我们已经证明,在饮用水中添加2%的胆固醇和铜会阻碍学习,但其他研究表明,在学习前摄入膳食胆固醇可以提高习得性,而在学习后摄入胆固醇会降低长期记忆。我们将探讨这个模型的发展,围绕铜的作用的问题,以及已故的D. Larry Sparks的特殊贡献。
{"title":"Cholesterol and copper affect learning and memory in the rabbit.","authors":"Bernard G Schreurs","doi":"10.1155/2013/518780","DOIUrl":"https://doi.org/10.1155/2013/518780","url":null,"abstract":"<p><p>A rabbit model of Alzheimer's disease based on feeding a cholesterol diet for eight weeks shows sixteen hallmarks of the disease including beta amyloid accumulation and learning and memory changes. Although we have shown that feeding 2% cholesterol and adding copper to the drinking water can retard learning, other studies have shown that feeding dietary cholesterol before learning can improve acquisition and feeding cholesterol after learning can degrade long-term memory. We explore the development of this model, the issues surrounding the role of copper, and the particular contributions of the late D. Larry Sparks. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"518780"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/518780","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31764130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Neuroinflammation and copper in Alzheimer's disease. 阿尔茨海默病中的神经炎症和铜。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-11-28 DOI: 10.1155/2013/145345
Xin Yi Choo, Lobna Alukaidey, Anthony R White, Alexandra Grubman

Inflammation is the innate immune response to infection or tissue damage. Initiation of proinflammatory cascades in the central nervous system (CNS) occurs through recognition of danger associated molecular patterns by cognate immune receptors expressed on inflammatory cells and leads to rapid responses to remove the danger stimulus. The presence of activated microglia and astrocytes in the vicinity of amyloid plaques in the brains of Alzheimer's disease (AD) patients and mouse models implicates inflammation as a contributor to AD pathogenesis. Activated microglia play a critical role in amyloid clearance, but chronic deregulation of CNS inflammatory pathways results in secretion of neurotoxic mediators that ultimately contribute to neurodegeneration in AD. Copper (Cu) homeostasis is profoundly affected in AD, and accumulated extracellular Cu drives A β aggregation, while intracellular Cu deficiency limits bioavailable Cu required for CNS functions. This review presents an overview of inflammatory events that occur in AD in response to A β and highlights recent advances on the role of Cu in modulation of beneficial and detrimental inflammatory responses in AD.

炎症是对感染或组织损伤的先天免疫反应。中枢神经系统(CNS)通过炎症细胞上表达的同源免疫受体对危险相关分子模式的识别而启动促炎级联反应,并导致快速反应以消除危险刺激。在阿尔茨海默病(AD)患者和小鼠模型的大脑中,淀粉样斑块附近存在活化的小胶质细胞和星形胶质细胞,这表明炎症是AD发病的一个因素。激活的小胶质细胞在淀粉样蛋白清除中起关键作用,但中枢神经系统炎症通路的慢性失调导致神经毒性介质的分泌,最终导致AD患者的神经变性。铜(Cu)稳态在AD中受到深刻影响,细胞外积累的Cu驱动A β聚集,而细胞内Cu缺乏限制了CNS功能所需的生物可利用铜。本文综述了阿尔茨海默病中发生的A β反应炎症事件,并重点介绍了Cu在阿尔茨海默病中有益和有害炎症反应调节中的最新进展。
{"title":"Neuroinflammation and copper in Alzheimer's disease.","authors":"Xin Yi Choo,&nbsp;Lobna Alukaidey,&nbsp;Anthony R White,&nbsp;Alexandra Grubman","doi":"10.1155/2013/145345","DOIUrl":"https://doi.org/10.1155/2013/145345","url":null,"abstract":"<p><p>Inflammation is the innate immune response to infection or tissue damage. Initiation of proinflammatory cascades in the central nervous system (CNS) occurs through recognition of danger associated molecular patterns by cognate immune receptors expressed on inflammatory cells and leads to rapid responses to remove the danger stimulus. The presence of activated microglia and astrocytes in the vicinity of amyloid plaques in the brains of Alzheimer's disease (AD) patients and mouse models implicates inflammation as a contributor to AD pathogenesis. Activated microglia play a critical role in amyloid clearance, but chronic deregulation of CNS inflammatory pathways results in secretion of neurotoxic mediators that ultimately contribute to neurodegeneration in AD. Copper (Cu) homeostasis is profoundly affected in AD, and accumulated extracellular Cu drives A β aggregation, while intracellular Cu deficiency limits bioavailable Cu required for CNS functions. This review presents an overview of inflammatory events that occur in AD in response to A β and highlights recent advances on the role of Cu in modulation of beneficial and detrimental inflammatory responses in AD. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"145345"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/145345","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31982320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 51
Sensorimotor Cortex Reorganization in Alzheimer's Disease and Metal Dysfunction: A MEG Study. 阿尔茨海默病和金属功能障碍的感觉运动皮层重组:一项MEG研究。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-12-12 DOI: 10.1155/2013/638312
C Salustri, F Tecchio, F Zappasodi, L Tomasevic, M Ercolani, F Moffa, E Cassetta, P M Rossini, R Squitti

Objective. To verify whether systemic biometals dysfunctions affect neurotransmission in living Alzheimer's disease (AD) patients. Methods. We performed a case-control study using magnetoencephalography to detect sensorimotor fields of AD patients, at rest and during median nerve stimulation. We analyzed position and amount of neurons synchronously activated by the stimulation in both hemispheres to investigate the capability of the primary somatosensory cortex to reorganize its circuitry disrupted by the disease. We also assessed systemic levels of copper, ceruloplasmin, non-Cp copper (i.e., copper not bound to ceruloplasmin), peroxides, transferrin, and total antioxidant capacity. Results. Patients' sensorimotor generators appeared spatially shifted, despite no change of latency and strength, while spontaneous activity sources appeared unchanged. Neuronal reorganization was greater in moderately ill patients, while delta activity increased in severe patients. Non-Cp copper was the only biological variable appearing to be associated with patient sensorimotor transmission. Conclusions. Our data strengthen the notion that non-Cp copper, not copper in general, affects neuronal activity in AD. Significance. High plasticity in the disease early stages in regions controlling more commonly used body parts strengthens the notion that physical and cognitive activities are protective factors against progression of dementia.

目标。验证系统性生物金属功能障碍是否影响阿尔茨海默病(AD)患者的神经传递。方法。我们进行了一项病例对照研究,使用脑磁图检测AD患者在休息和正中神经刺激时的感觉运动野。我们分析了在两个大脑半球同时被刺激激活的神经元的位置和数量,以研究初级体感觉皮层重组其被疾病破坏的电路的能力。我们还评估了全身铜、铜蓝蛋白、非cp铜(即未与铜蓝蛋白结合的铜)、过氧化物、转铁蛋白和总抗氧化能力的水平。结果。患者的感觉运动发生器出现空间移位,但潜伏期和强度没有变化,而自发活动源没有变化。中度患者的神经元重组更大,而重度患者的δ活动增加。非cp铜是唯一与患者感觉运动传递相关的生物学变量。结论。我们的数据加强了非cp铜的概念,而不是一般的铜,影响阿尔茨海默病的神经元活动。的意义。在疾病早期阶段,控制更常用身体部位的区域具有高度可塑性,这加强了身体和认知活动是防止痴呆症进展的保护因素的概念。
{"title":"Sensorimotor Cortex Reorganization in Alzheimer's Disease and Metal Dysfunction: A MEG Study.","authors":"C Salustri,&nbsp;F Tecchio,&nbsp;F Zappasodi,&nbsp;L Tomasevic,&nbsp;M Ercolani,&nbsp;F Moffa,&nbsp;E Cassetta,&nbsp;P M Rossini,&nbsp;R Squitti","doi":"10.1155/2013/638312","DOIUrl":"https://doi.org/10.1155/2013/638312","url":null,"abstract":"<p><p>Objective. To verify whether systemic biometals dysfunctions affect neurotransmission in living Alzheimer's disease (AD) patients. Methods. We performed a case-control study using magnetoencephalography to detect sensorimotor fields of AD patients, at rest and during median nerve stimulation. We analyzed position and amount of neurons synchronously activated by the stimulation in both hemispheres to investigate the capability of the primary somatosensory cortex to reorganize its circuitry disrupted by the disease. We also assessed systemic levels of copper, ceruloplasmin, non-Cp copper (i.e., copper not bound to ceruloplasmin), peroxides, transferrin, and total antioxidant capacity. Results. Patients' sensorimotor generators appeared spatially shifted, despite no change of latency and strength, while spontaneous activity sources appeared unchanged. Neuronal reorganization was greater in moderately ill patients, while delta activity increased in severe patients. Non-Cp copper was the only biological variable appearing to be associated with patient sensorimotor transmission. Conclusions. Our data strengthen the notion that non-Cp copper, not copper in general, affects neuronal activity in AD. Significance. High plasticity in the disease early stages in regions controlling more commonly used body parts strengthens the notion that physical and cognitive activities are protective factors against progression of dementia. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"638312"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/638312","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32022317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
The Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeleton. 阿尔茨海默病的β -淀粉样蛋白:通过改变神经元细胞骨架导致通讯中断。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-12-12 DOI: 10.1155/2013/910502
Sara H Mokhtar, Maha M Bakhuraysah, David S Cram, Steven Petratos

Alzheimer's disease (AD) is one of the most prevalent severe neurological disorders afflicting our aged population. Cognitive decline, a major symptom exhibited by AD patients, is associated with neuritic dystrophy, a degenerative growth state of neurites. The molecular mechanisms governing neuritic dystrophy remain unclear. Mounting evidence indicates that the AD-causative agent, β -amyloid protein (A β ), induces neuritic dystrophy. Indeed, neuritic dystrophy is commonly found decorating A β -rich amyloid plaques (APs) in the AD brain. Furthermore, disruption and degeneration of the neuronal microtubule system in neurons forming dystrophic neurites may occur as a consequence of A β -mediated downstream signaling. This review defines potential molecular pathways, which may be modulated subsequent to A β -dependent interactions with the neuronal membrane as a consequence of increasing amyloid burden in the brain.

阿尔茨海默病(AD)是困扰我国老年人口的最普遍的严重神经系统疾病之一。认知能力下降是阿尔茨海默病患者的主要症状,与神经性营养不良有关,这是一种神经突的退行性生长状态。控制神经性营养不良的分子机制尚不清楚。越来越多的证据表明,ad的病原体β -淀粉样蛋白(A β)可诱导神经营养不良。事实上,阿尔茨海默病大脑中富含A β的淀粉样斑块(APs)通常会出现神经性营养不良。此外,a β介导的下游信号传导可能导致神经元微管系统的破坏和退化,形成营养不良的神经突。这篇综述定义了潜在的分子通路,这可能是由于大脑中淀粉样蛋白负荷增加而导致的A β依赖性与神经元膜相互作用的结果。
{"title":"The Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeleton.","authors":"Sara H Mokhtar,&nbsp;Maha M Bakhuraysah,&nbsp;David S Cram,&nbsp;Steven Petratos","doi":"10.1155/2013/910502","DOIUrl":"https://doi.org/10.1155/2013/910502","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is one of the most prevalent severe neurological disorders afflicting our aged population. Cognitive decline, a major symptom exhibited by AD patients, is associated with neuritic dystrophy, a degenerative growth state of neurites. The molecular mechanisms governing neuritic dystrophy remain unclear. Mounting evidence indicates that the AD-causative agent, β -amyloid protein (A β ), induces neuritic dystrophy. Indeed, neuritic dystrophy is commonly found decorating A β -rich amyloid plaques (APs) in the AD brain. Furthermore, disruption and degeneration of the neuronal microtubule system in neurons forming dystrophic neurites may occur as a consequence of A β -mediated downstream signaling. This review defines potential molecular pathways, which may be modulated subsequent to A β -dependent interactions with the neuronal membrane as a consequence of increasing amyloid burden in the brain. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"910502"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/910502","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32022318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 55
Care for Alzheimer's disease. 照顾老年痴呆症。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-04-18 DOI: 10.1155/2013/516852
Hiroyuki Umegaki, Hajime Takechi, Hiroko H Dodge
Cognitive impairment due to dementia deprives those afflicted with the disease of their autonomy and ability to take care of themselves, making them dependent on care provided by formal and informal resources. Moreover, as the disease progresses, behavioral and psychological symptoms of dementia (BPSD) may occur. BPSD are often troublesome to both caregivers and the patients themselves. The care burden is often heavy and disrupts the lives of family members surrounding the patient. Early screening and identification of cognitive decline will help those with the disease and family members prepare for better care and may reduce the patients' BPSD. Effective screening for dementia, which can be administered at ambulatory care facilities, is warranted. Vascular risk factors, especially type 2 diabetes mellitus, have been found to increase the risk of developing Alzheimer's disease (AD). The prevalence of type 2 diabetes mellitus is increasing in Japan. In this special issue, T. Matsuzawa et al. describe an index for screening for mild or moderate AD cases among the elderly with type 2 diabetes mellitus. The index includes self-reported answers to a questionnaire regarding subjective memory complaints and daily functioning and information on vascular risk factors obtained from clinical charts. The index had satisfactory discriminatory ability to identify those with AD among patients with diabetes. This may contribute to an effective screening for AD among those with diabetes, that is, known high-risk populations. Current treatments for AD are limited to alleviating symptoms, but not reversing the pathological progress. Pharmacological treatments for BPSD, which are critical for the well-being of both patients and caregivers, are also limited in their effectiveness. The study by H. Fukui et al. examines changes in sex hormones associated with the pathogenesis of AD before and after music therapy among patients with AD. They show that music therapy modified the secretion of sex hormones, and the results also suggest that problematic behavior may be reduced this way. The therapy has the potential to become a safe alternative treatment that is as effective as hormone replacement, but with fewer side effects. The underlying biological mechanism of effects shown in this study is convincing and a welcome addition to the field. The number of those suffering from dementia is increasing worldwide. Effective caregiving strategies and targeted care management programs are urgently needed to enhance the well-being of those with AD and their caregivers. T. Passos et al. examined the met and unmet needs of the elderly with mental health problems and their care in Portugal. The main unmet needs identified were daytime activities, social benefits, company, psychological distress, and incontinence. Some of these unmet needs may be universal across countries worldwide, but others may differ depending on specific health care systems and cultures. A comparison wi
{"title":"Care for Alzheimer's disease.","authors":"Hiroyuki Umegaki,&nbsp;Hajime Takechi,&nbsp;Hiroko H Dodge","doi":"10.1155/2013/516852","DOIUrl":"https://doi.org/10.1155/2013/516852","url":null,"abstract":"Cognitive impairment due to dementia deprives those afflicted with the disease of their autonomy and ability to take care of themselves, making them dependent on care provided by formal and informal resources. Moreover, as the disease progresses, behavioral and psychological symptoms of dementia (BPSD) may occur. BPSD are often troublesome to both caregivers and the patients themselves. The care burden is often heavy and disrupts the lives of family members surrounding the patient. \u0000 \u0000Early screening and identification of cognitive decline will help those with the disease and family members prepare for better care and may reduce the patients' BPSD. Effective screening for dementia, which can be administered at ambulatory care facilities, is warranted. Vascular risk factors, especially type 2 diabetes mellitus, have been found to increase the risk of developing Alzheimer's disease (AD). The prevalence of type 2 diabetes mellitus is increasing in Japan. In this special issue, T. Matsuzawa et al. describe an index for screening for mild or moderate AD cases among the elderly with type 2 diabetes mellitus. The index includes self-reported answers to a questionnaire regarding subjective memory complaints and daily functioning and information on vascular risk factors obtained from clinical charts. The index had satisfactory discriminatory ability to identify those with AD among patients with diabetes. This may contribute to an effective screening for AD among those with diabetes, that is, known high-risk populations. \u0000 \u0000Current treatments for AD are limited to alleviating symptoms, but not reversing the pathological progress. Pharmacological treatments for BPSD, which are critical for the well-being of both patients and caregivers, are also limited in their effectiveness. The study by H. Fukui et al. examines changes in sex hormones associated with the pathogenesis of AD before and after music therapy among patients with AD. They show that music therapy modified the secretion of sex hormones, and the results also suggest that problematic behavior may be reduced this way. The therapy has the potential to become a safe alternative treatment that is as effective as hormone replacement, but with fewer side effects. The underlying biological mechanism of effects shown in this study is convincing and a welcome addition to the field. \u0000 \u0000The number of those suffering from dementia is increasing worldwide. Effective caregiving strategies and targeted care management programs are urgently needed to enhance the well-being of those with AD and their caregivers. T. Passos et al. examined the met and unmet needs of the elderly with mental health problems and their care in Portugal. The main unmet needs identified were daytime activities, social benefits, company, psychological distress, and incontinence. Some of these unmet needs may be universal across countries worldwide, but others may differ depending on specific health care systems and cultures. A comparison wi","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"516852"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/516852","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31458640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of the mini-cog for detection of cognitive impairment in primary care: data from two spanish studies. mini-cog在初级保健中检测认知障碍的效用:来自两项西班牙研究的数据。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-08-28 DOI: 10.1155/2013/285462
Cristóbal Carnero-Pardo, Isabel Cruz-Orduña, Beatriz Espejo-Martínez, Carolina Martos-Aparicio, Samuel López-Alcalde, Javier Olazarán

Objectives. To study the utility of the Mini-Cog test for detection of patients with cognitive impairment (CI) in primary care (PC). Methods. We pooled data from two phase III studies conducted in Spain. Patients with complaints or suspicion of CI were consecutively recruited by PC physicians. The cognitive diagnosis was performed by an expert neurologist, after formal neuropsychological evaluation. The Mini-Cog score was calculated post hoc, and its diagnostic utility was evaluated and compared with the utility of the Mini-Mental State (MMS), the Clock Drawing Test (CDT), and the sum of the MMS and the CDT (MMS + CDT) using the area under the receiver operating characteristic curve (AUC). The best cut points were obtained on the basis of diagnostic accuracy (DA) and kappa index. Results. A total sample of 307 subjects (176 CI) was analyzed. The Mini-Cog displayed an AUC (±SE) of 0.78 ± 0.02, which was significantly inferior to the AUC of the CDT (0.84 ± 0.02), the MMS (0.84 ± 0.02), and the MMS + CDT (0.86 ± 0.02). The best cut point of the Mini-Cog was 1/2 (sensitivity 0.60, specificity 0.90, DA 0.73, and kappa index 0.48 ± 0.05). Conclusions. The utility of the Mini-Cog for detection of CI in PC was very modest, clearly inferior to the MMS or the CDT. These results do not permit recommendation of the Mini-Cog in PC.

目标。目的:探讨Mini-Cog试验在初级保健(PC)患者认知功能障碍(CI)检测中的应用价值。方法。我们汇集了在西班牙进行的两项III期研究的数据。主诉或怀疑CI的患者由PC医师连续招募。认知诊断是在正式的神经心理学评估后由一位神经专家进行的。事后计算Mini-Cog评分,评估其诊断效用,并与Mini-Mental State (MMS)、Clock Drawing Test (CDT)和MMS与CDT的总和(MMS + CDT)的效用进行比较,采用受试者工作特征曲线下面积(AUC)。根据诊断准确度(DA)和kappa指数确定最佳切点。结果。共分析307例受试者(176 CI)。Mini-Cog的AUC(±SE)为0.78±0.02,明显低于CDT(0.84±0.02)、MMS(0.84±0.02)和MMS + CDT(0.86±0.02)的AUC。Mini-Cog的最佳切割点为1/2(敏感性0.60,特异性0.90,DA 0.73, kappa指数0.48±0.05)。结论。Mini-Cog在PC中检测CI的效用非常有限,明显不如MMS或CDT。这些结果不允许在PC中推荐Mini-Cog。
{"title":"Utility of the mini-cog for detection of cognitive impairment in primary care: data from two spanish studies.","authors":"Cristóbal Carnero-Pardo,&nbsp;Isabel Cruz-Orduña,&nbsp;Beatriz Espejo-Martínez,&nbsp;Carolina Martos-Aparicio,&nbsp;Samuel López-Alcalde,&nbsp;Javier Olazarán","doi":"10.1155/2013/285462","DOIUrl":"https://doi.org/10.1155/2013/285462","url":null,"abstract":"<p><p>Objectives. To study the utility of the Mini-Cog test for detection of patients with cognitive impairment (CI) in primary care (PC). Methods. We pooled data from two phase III studies conducted in Spain. Patients with complaints or suspicion of CI were consecutively recruited by PC physicians. The cognitive diagnosis was performed by an expert neurologist, after formal neuropsychological evaluation. The Mini-Cog score was calculated post hoc, and its diagnostic utility was evaluated and compared with the utility of the Mini-Mental State (MMS), the Clock Drawing Test (CDT), and the sum of the MMS and the CDT (MMS + CDT) using the area under the receiver operating characteristic curve (AUC). The best cut points were obtained on the basis of diagnostic accuracy (DA) and kappa index. Results. A total sample of 307 subjects (176 CI) was analyzed. The Mini-Cog displayed an AUC (±SE) of 0.78 ± 0.02, which was significantly inferior to the AUC of the CDT (0.84 ± 0.02), the MMS (0.84 ± 0.02), and the MMS + CDT (0.86 ± 0.02). The best cut point of the Mini-Cog was 1/2 (sensitivity 0.60, specificity 0.90, DA 0.73, and kappa index 0.48 ± 0.05). Conclusions. The utility of the Mini-Cog for detection of CI in PC was very modest, clearly inferior to the MMS or the CDT. These results do not permit recommendation of the Mini-Cog in PC. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"285462"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/285462","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31761376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
Role of copper and cholesterol association in the neurodegenerative process. 铜和胆固醇在神经退行性过程中的作用。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-10-29 DOI: 10.1155/2013/414817
Nathalie Arnal, Gustavo R Morel, María J T de Alaniz, Omar Castillo, Carlos A Marra

Age is one of the main factors involved in the development of neurological illnesses, in particular, Alzheimer, and it is widely held that the rapid aging of the world population is accompanied by a rise in the prevalence and incidence of Alzheimer disease. However, evidence from recent decades indicates that Cu and Cho overload are emerging causative factors in neurodegeneration, a hypothesis that has been partially investigated in experimental models. The link between these two variables and the onset of Alzheimer disease has opened up interesting new possibilities requiring more in-depth analysis. The aim of the present study was therefore to investigate the effect of the association of Cu + Cho (CuCho) as a possible synergistic factor in the development of an Alzheimer-like pathology in Wistar rats. We measured total- and nonceruloplasmin-bound Cu and Cho (free and sterified) contents in plasma and brain zones (cortex and hippocampus), markers of oxidative stress damage, inflammation, and programmed cell death (caspase-3 and calpain isoforms). The ratio beta-amyloid (1-42)/(1-40) was determined in plasma and brain as neurodegenerative biomarker. An evaluation of visuospatial memory (Barnes maze test) was also performed. The results demonstrate the establishment of a prooxidative and proinflammatory environment after CuCho treatment, hallmarked by increased TBARS, protein carbonyls, and nitrite plus nitrate levels in plasma and brain zones (cortex and hippocampus) with a consequent increase in the activity of calpains and no significant changes in caspase-3. A simultaneous increase in the plasma A β 1-42/A β 1-40 ratio was found. Furthermore, a slight but noticeable change in visuospatial memory was observed in rats treated with CuCho. We conclude that our model could reflect an initial stage of neurodegeneration in which Cu and Cho interact with one another to exacerbate neurological damage.

年龄是神经系统疾病,特别是阿尔茨海默病发展的主要因素之一,人们普遍认为,世界人口的迅速老龄化伴随着阿尔茨海默病的患病率和发病率的上升。然而,近几十年来的证据表明,Cu和Cho超载是神经变性的新病因,这一假设已在实验模型中得到部分研究。这两个变量与阿尔茨海默病发病之间的联系开辟了有趣的新可能性,需要更深入的分析。因此,本研究的目的是研究Cu + Cho (CuCho)作为Wistar大鼠阿尔茨海默样病理发展中可能的协同因子的作用。我们测量了血浆和脑区(皮质和海马)中总铜蓝蛋白和非铜蓝蛋白结合的Cu和Cho(游离和sterded)含量,以及氧化应激损伤、炎症和程序性细胞死亡的标志物(caspase-3和calpain亚型)。测定血浆和脑组织中β -淀粉样蛋白(1-42)/(1-40)的比值作为神经退行性生物标志物。视觉空间记忆的评估(巴恩斯迷宫测试)也进行了。结果表明,CuCho治疗后建立了一个促氧化和促炎症的环境,其特点是血浆和脑区(皮质和海马)中TBARS、蛋白羰基和亚硝酸盐和硝酸盐水平增加,钙蛋白酶活性随之增加,而caspase-3无显著变化。血浆A β 1-42/A β 1-40比值同时升高。此外,用CuCho治疗的大鼠的视觉空间记忆有轻微但明显的变化。我们的结论是,我们的模型可以反映神经退行性变的初始阶段,其中Cu和Cho相互作用加剧神经损伤。
{"title":"Role of copper and cholesterol association in the neurodegenerative process.","authors":"Nathalie Arnal,&nbsp;Gustavo R Morel,&nbsp;María J T de Alaniz,&nbsp;Omar Castillo,&nbsp;Carlos A Marra","doi":"10.1155/2013/414817","DOIUrl":"https://doi.org/10.1155/2013/414817","url":null,"abstract":"<p><p>Age is one of the main factors involved in the development of neurological illnesses, in particular, Alzheimer, and it is widely held that the rapid aging of the world population is accompanied by a rise in the prevalence and incidence of Alzheimer disease. However, evidence from recent decades indicates that Cu and Cho overload are emerging causative factors in neurodegeneration, a hypothesis that has been partially investigated in experimental models. The link between these two variables and the onset of Alzheimer disease has opened up interesting new possibilities requiring more in-depth analysis. The aim of the present study was therefore to investigate the effect of the association of Cu + Cho (CuCho) as a possible synergistic factor in the development of an Alzheimer-like pathology in Wistar rats. We measured total- and nonceruloplasmin-bound Cu and Cho (free and sterified) contents in plasma and brain zones (cortex and hippocampus), markers of oxidative stress damage, inflammation, and programmed cell death (caspase-3 and calpain isoforms). The ratio beta-amyloid (1-42)/(1-40) was determined in plasma and brain as neurodegenerative biomarker. An evaluation of visuospatial memory (Barnes maze test) was also performed. The results demonstrate the establishment of a prooxidative and proinflammatory environment after CuCho treatment, hallmarked by increased TBARS, protein carbonyls, and nitrite plus nitrate levels in plasma and brain zones (cortex and hippocampus) with a consequent increase in the activity of calpains and no significant changes in caspase-3. A simultaneous increase in the plasma A β 1-42/A β 1-40 ratio was found. Furthermore, a slight but noticeable change in visuospatial memory was observed in rats treated with CuCho. We conclude that our model could reflect an initial stage of neurodegeneration in which Cu and Cho interact with one another to exacerbate neurological damage. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"414817"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/414817","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31911744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Acetylcholinesterase inhibitors promote angiogenesis in chick chorioallantoic membrane and inhibit apoptosis of endothelial cells. 乙酰胆碱酯酶抑制剂促进小鸡绒毛膜血管生成并抑制内皮细胞凋亡
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-09-16 DOI: 10.1155/2013/121068
Seyed Mohsen Mortazavian, Heydar Parsaee, Seyed Hadi Mousavi, Zahra Tayarani-Najaran, Ahmad Ghorbani, Hamid Reza Sadeghnia

Alzheimer's disease (AD) is one of the most common causes of dementia in the elderly. Recently, a great attention has been paid to the possible role of vascular changes in the pathogenesis of AD. Reduced microvascular density and degeneration of the endothelium are of structural cerebrovascular changes in AD. Acetylcholinesterase (AChE) inhibitors are widely used for the improvement of AD symptoms. Until now, however, the effects of AChE inhibitors on vascular changes including angiogenesis and endothelial cell apoptosis are not fully understood. In the present work, the effects of three AChE inhibitors (donepezil, rivastigmine, and galantamine) were tested on H2O2-induced apoptosis in human umbilical vein endothelial cells (HUVECs) and on angiogenesis in chicken chorioallantoic membrane model. Incubation of HUVEC with H2O2 led to a significant decrease in cell viability and an increase in the percentage of apoptotic cells. The tested drugs, at concentrations of 1-100  μ M, significantly inhibited the H2O2-induced toxicity. Also, all donepezil, rivastigmine and galantamine significantly increased the number of vessels in the chorioallantoic membrane when injected into fertilized eggs. In conclusion, AChE inhibitors possess angiogenesis-accelerating properties and have antiapoptotic effects on endothelial cells. These effects of AChE inhibitors may be involved in their beneficial effects on AD.

阿尔茨海默病(AD)是导致老年人痴呆症的最常见原因之一。最近,血管变化在阿尔茨海默病发病机制中可能扮演的角色受到了极大关注。微血管密度降低和内皮变性是老年痴呆症的脑血管结构性变化。乙酰胆碱酯酶(AChE)抑制剂被广泛用于改善 AD 症状。然而,迄今为止,乙酰胆碱酯酶抑制剂对血管变化(包括血管生成和内皮细胞凋亡)的影响尚未完全明了。本研究测试了三种 AChE 抑制剂(多奈哌齐、利伐斯的明和加兰他敏)对 H2O2 诱导的人脐静脉内皮细胞(HUVECs)凋亡和鸡绒毛膜模型血管生成的影响。用 H2O2 培养 HUVEC 会导致细胞存活率显著下降,凋亡细胞的百分比增加。浓度为 1-100 μ M 的受试药物能显著抑制 H2O2 诱导的毒性。此外,将多奈哌齐、利伐斯的明和加兰他敏注射到受精卵中,它们都能明显增加绒毛膜中的血管数量。总之,乙酰胆碱酯酶抑制剂具有促进血管生成的特性,并对内皮细胞具有抗凋亡作用。AChE 抑制剂的这些作用可能是其对注意力缺失症产生有益影响的原因。
{"title":"Acetylcholinesterase inhibitors promote angiogenesis in chick chorioallantoic membrane and inhibit apoptosis of endothelial cells.","authors":"Seyed Mohsen Mortazavian, Heydar Parsaee, Seyed Hadi Mousavi, Zahra Tayarani-Najaran, Ahmad Ghorbani, Hamid Reza Sadeghnia","doi":"10.1155/2013/121068","DOIUrl":"10.1155/2013/121068","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is one of the most common causes of dementia in the elderly. Recently, a great attention has been paid to the possible role of vascular changes in the pathogenesis of AD. Reduced microvascular density and degeneration of the endothelium are of structural cerebrovascular changes in AD. Acetylcholinesterase (AChE) inhibitors are widely used for the improvement of AD symptoms. Until now, however, the effects of AChE inhibitors on vascular changes including angiogenesis and endothelial cell apoptosis are not fully understood. In the present work, the effects of three AChE inhibitors (donepezil, rivastigmine, and galantamine) were tested on H2O2-induced apoptosis in human umbilical vein endothelial cells (HUVECs) and on angiogenesis in chicken chorioallantoic membrane model. Incubation of HUVEC with H2O2 led to a significant decrease in cell viability and an increase in the percentage of apoptotic cells. The tested drugs, at concentrations of 1-100  μ M, significantly inhibited the H2O2-induced toxicity. Also, all donepezil, rivastigmine and galantamine significantly increased the number of vessels in the chorioallantoic membrane when injected into fertilized eggs. In conclusion, AChE inhibitors possess angiogenesis-accelerating properties and have antiapoptotic effects on endothelial cells. These effects of AChE inhibitors may be involved in their beneficial effects on AD. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":" ","pages":"121068"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40265989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical trial of a home safety toolkit for Alzheimer's disease. 阿尔茨海默病家庭安全工具包临床试验。
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-09-29 DOI: 10.1155/2013/913606
Kathy J Horvath, Scott A Trudeau, James L Rudolph, Paulette A Trudeau, Mary E Duffy, Dan Berlowitz

This randomized clinical trial tested a new self-directed educational intervention to improve caregiver competence to create a safer home environment for persons with dementia living in the community. The sample included 108 patient/caregiver dyads: the intervention group (n = 60) received the Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items to enhance self-efficacy to make home safety modifications. The control group (n = 48) received customary care. Participants completed measures at baseline and at twelve-week follow-up. Multivariate Analysis of Covariance (MANCOVA) was used to test for significant group differences. All caregiver outcome variables improved in the intervention group more than in the control. Home safety was significant at P ≤ 0.001, caregiver strain at P ≤ 0.001, and caregiver self-efficacy at P = 0.002. Similarly, the care receiver outcome of risky behaviors and accidents was lower in the intervention group (P ≤ 0.001). The self-directed use of this Home Safety Toolkit activated the primary family caregiver to make the home safer for the person with dementia of Alzheimer's type (DAT) or related disorder. Improving the competence of informal caregivers is especially important for patients with DAT in light of all stakeholders reliance on their unpaid care.

这项随机临床试验测试了一种新的自主教育干预措施,旨在提高护理人员的能力,为居住在社区的痴呆症患者创造更安全的家庭环境。样本包括 108 个患者/照护者二人组:干预组(n = 60)接受家庭安全工具包(HST),包括一本基于健康知识原则的新手册和安全项目样本,以提高进行家庭安全改造的自我效能。对照组(48 人)接受常规护理。参与者在基线和 12 周的随访中完成了测量。多变量协方差分析(MANCOVA)用于检验组间差异是否显著。与对照组相比,干预组护理人员的所有结果变量都得到了改善。家庭安全的显著性(P≤ 0.001)、护理人员压力的显著性(P≤ 0.001)和护理人员自我效能的显著性(P = 0.002)。同样,干预组接受护理者的危险行为和事故发生率也较低(P ≤ 0.001)。通过自主使用家庭安全工具包,主要家庭照顾者能够为阿尔茨海默型痴呆症(DAT)患者或相关疾病患者提供更安全的居家环境。鉴于所有利益相关者都依赖于非正规照顾者的无偿照顾,因此提高非正规照顾者的能力对老年痴呆症患者尤为重要。
{"title":"Clinical trial of a home safety toolkit for Alzheimer's disease.","authors":"Kathy J Horvath, Scott A Trudeau, James L Rudolph, Paulette A Trudeau, Mary E Duffy, Dan Berlowitz","doi":"10.1155/2013/913606","DOIUrl":"10.1155/2013/913606","url":null,"abstract":"<p><p>This randomized clinical trial tested a new self-directed educational intervention to improve caregiver competence to create a safer home environment for persons with dementia living in the community. The sample included 108 patient/caregiver dyads: the intervention group (n = 60) received the Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items to enhance self-efficacy to make home safety modifications. The control group (n = 48) received customary care. Participants completed measures at baseline and at twelve-week follow-up. Multivariate Analysis of Covariance (MANCOVA) was used to test for significant group differences. All caregiver outcome variables improved in the intervention group more than in the control. Home safety was significant at P ≤ 0.001, caregiver strain at P ≤ 0.001, and caregiver self-efficacy at P = 0.002. Similarly, the care receiver outcome of risky behaviors and accidents was lower in the intervention group (P ≤ 0.001). The self-directed use of this Home Safety Toolkit activated the primary family caregiver to make the home safer for the person with dementia of Alzheimer's type (DAT) or related disorder. Improving the competence of informal caregivers is especially important for patients with DAT in light of all stakeholders reliance on their unpaid care. </p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"913606"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31835869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
γ -Secretase Pharmacology: What Pharmacology Will Work for Alzheimer's Disease? γ -分泌酶药理学:什么药理学将对阿尔茨海默病起作用?
Q1 Neuroscience Pub Date : 2013-01-01 Epub Date: 2013-04-18 DOI: 10.1155/2013/849128
Jeremy H Toyn, Adele Rowley, Yasuji Matsuoka, Taisuke Tomita, Bruno P Imbimbo
This special issue focuses on γ-secretase modulators (GSMs) and inhibitors (GSIs), two classes of small molecules with the potential to test the amyloid hypothesis of Alzheimer's disease. Recent clinical trials of GSI and GSM, including semagacestat, avagacestat, and R-flurbiprofen, have been discontinued for lack of efficacy and/or side effects, the mechanisms of which have not been elucidated. Detrimental effects of GSIs on cognition observed in AD patients may be linked to the accumulation of C-terminal fragment of APP (C99 or CTFβ). The stimulating effects of GSIs on skin cancer in AD patients have been linked to their inhibition of Notch processing. The lack of efficacy of the GSM R-flurbiprofen in AD patients has been explained with its low potency and poor ability to cross the blood-brain barrier. The two review articles and three research articles address key issues for GSI and GSM, namely, Notch-related side effects and drug-like properties, respectively. Although other amyloid-related approaches are continuing in clinical trials, including anti-Aβ antibodies and β-site amyloid precursor protein cleaving enzyme (BACE) inhibitors, it still remains to be seen whether or not they can decrease amyloid or Aβ for a sufficient period of time at tolerable doses in patients. Therefore, renewed efforts toward GSIs and GSMs appear justified.
{"title":"γ -Secretase Pharmacology: What Pharmacology Will Work for Alzheimer's Disease?","authors":"Jeremy H Toyn,&nbsp;Adele Rowley,&nbsp;Yasuji Matsuoka,&nbsp;Taisuke Tomita,&nbsp;Bruno P Imbimbo","doi":"10.1155/2013/849128","DOIUrl":"https://doi.org/10.1155/2013/849128","url":null,"abstract":"This special issue focuses on γ-secretase modulators (GSMs) and inhibitors (GSIs), two classes of small molecules with the potential to test the amyloid hypothesis of Alzheimer's disease. Recent clinical trials of GSI and GSM, including semagacestat, avagacestat, and R-flurbiprofen, have been discontinued for lack of efficacy and/or side effects, the mechanisms of which have not been elucidated. Detrimental effects of GSIs on cognition observed in AD patients may be linked to the accumulation of C-terminal fragment of APP (C99 or CTFβ). The stimulating effects of GSIs on skin cancer in AD patients have been linked to their inhibition of Notch processing. The lack of efficacy of the GSM R-flurbiprofen in AD patients has been explained with its low potency and poor ability to cross the blood-brain barrier. The two review articles and three research articles address key issues for GSI and GSM, namely, Notch-related side effects and drug-like properties, respectively. Although other amyloid-related approaches are continuing in clinical trials, including anti-Aβ antibodies and β-site amyloid precursor protein cleaving enzyme (BACE) inhibitors, it still remains to be seen whether or not they can decrease amyloid or Aβ for a sufficient period of time at tolerable doses in patients. Therefore, renewed efforts toward GSIs and GSMs appear justified.","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2013 ","pages":"849128"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/849128","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31458641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
International Journal of Alzheimer's Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1